U.S. Backs New Ebola Treatment; Candy-Like Tobacco Targeted; 1 in 10 Surgeons Quit

(MedPage Today) -- Note that some links may require registration or subscription. U.S. officials are working with Mapp Biopharmaceutical, a small biotech company based in San Diego, to provide an experimental monoclonal antibody treatment for...
Source
MedPage Today
Opens original article in a new tab



